• Portfolio
  • Latest Articles

CANNABIS PRODUCTS

May 21st

CPH expands its footprint with new product launch and entry into Eastern Europe

  Archived
Bod Australia appoints leading executive as CFO

April 12th 2021

Bod Australia appoints leading executive as CFO

CPH looks to expand its footprint as NY State reaches deal legalise recreational cannabis

April 6th 2021

CPH looks to expand its footprint as NY State reaches deal legalise recreational cannabis

$18M will help CPH progress near-term revenue initiatives

March 26th 2021

$18M will help CPH progress near-term revenue initiatives

Creso Pharma’s Mernova secures first sale for Ritual Sticks

March 19th 2021

Creso Pharma’s Mernova secures first sale for Ritual Sticks

Neurotech expands exclusive license to include all neurological disorders

March 2nd 2021

Neurotech expands exclusive license to include all neurological disorders

Creso Pharma's Mernova enters Canada’s largest recreational cannabis market

February 17th 2021

Creso Pharma's Mernova enters Canada’s largest recreational cannabis market

Creso Pharma bags four new orders and launches Black Mamba

February 3rd 2021

Creso Pharma bags four new orders and launches Black Mamba

Creso Pharma’s CBD for pets secures regulatory approval in Latin America

December 21st 2020

Creso Pharma’s CBD for pets secures regulatory approval in Latin America

Page 1 of 13 next >

Connect with us

EXPLORE

  • Finfeed Portfolio
  • Latest Articles
  • How It Works
  • Archived Articles
  • About StocksDigital
  • News
  • PORTFOLIOS

  • Next Investors
  • Catalyst Hunter
  • Wise-Owl
  • STOCKS

    FOLLOW OUR INVESTMENT COMMENTARY & ANALYSIS
      CUSTOMER NOTICE | PRIVACY POLICY | FINANCIAL SERVICES GUIDE | DISCLOSURE POLICY  
    The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).
    © 2021   |   AFSL (CAR No.433913)